| Literature DB >> 26329489 |
Rebecca Hays1, Gavin Daker-White2.
Abstract
BACKGROUND: Large, integrated datasets can be used to improve the identification and management of health conditions. However, big data initiatives are controversial because of risks to privacy. In 2014, NHS England launched a public awareness campaign about the care.data project, whereby data from patients' medical records would be regularly uploaded to a central database. Details of the project sparked intense debate across a number of platforms, including social media sites such as Twitter. Twitter is increasingly being used to educate and inform patients and care providers, and as a source of data for health services research. The aim of the study was to identify and describe the range of opinions expressed about care.data on Twitter for the period during which a delay to this project was announced, and provide insight into the strengths and flaws of the project.Entities:
Mesh:
Year: 2015 PMID: 26329489 PMCID: PMC4556193 DOI: 10.1186/s12889-015-2180-9
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1When and how many tweets were captured
List of key themes and sub-themes
| Key themes | Sub-themes | ||
|---|---|---|---|
| 1 | Informed consent and the default ‘opt-in’ | 1 | Opt-out versus opt-in |
| 2 | Informed consent | ||
| 3 | Patient access to GP records | ||
| 4 | Apathy regarding default ‘opt-in’ | ||
| 2 | Trust | 5 | Lack of trust |
| 3 | Privacy and data security | 6 | Identifiable data |
| 7 | Privacy | ||
| 8 | Security issues | ||
| 9 | Confidentiality of patient data | ||
| 10 | care.data has risks | ||
| 4 | Involvement of private companies | 11 | Data accessed by insurance companies |
| 12 | Data for sale | ||
| 13 | Concerns about the involvement of a private IT company | ||
| 14 | Data going to other private companies | ||
| 15 | Care.data linked to NHS privatisation | ||
| 5 | Legal issues and GPs’ concerns | 16 | Data protection |
| 17 | Legal issues | ||
| 18 | GPs' concerns | ||
| 19 | Concerns about adding genomic data later | ||
| 20 | Police access to care.data | ||
| 6 | Communication failure and confusion about care.data | 21 | Communication failure |
| 22 | Confusion about what care.data is | ||
| 23 | care.data as a media event | ||
| 24 | care.data leaflet and junk mail | ||
| 25 | Conflicts of interest | ||
| 26 | Public ignorance about care.data | ||
| 27 | Mainstream media reports on care.data | ||
| 28 | PR and presentation of facts | ||
| 29 | Critics accused of scaremongering | ||
| 7 | Delayed implementation | 30 | Delay to implementation |
| 31 | Role of activists or activism | ||
| 32 | Flawed project | ||
| 33 | Change management | ||
| 34 | Another NHS fiasco | ||
| 35 | Pause will not affect implementation | ||
| 36 | A failed brand | ||
| 37 | Costs of care.data project | ||
| 38 | Technological problems | ||
| 39 | Accuracy of medical records | ||
| 8 | Patient-centeredness | 40 | Arrogance |
| 41 | Lack of patient and public involvement | ||
| 42 | Lack of patient-centeredness | ||
| 43 | Patient ownership of medical data | ||
| 44 | Lack of engagement | ||
| 9 | Potential of care.data and the ideal model of implementation | 45 | Pro care.data viewpoint |
| 46 | Ideal model of implementation | ||
| 47 | Benefits of open data | ||
| 48 | Accusing critics of scaremongering | ||
| 49 | Use of patient data is not new | ||
| 50 | Moral imperative for care.data | ||
Fig. 2Conceptual map of key themes from Twitter discourse about care.data